The rise of big data: deep sequencing-driven computational methods are transforming the landscape of synthetic antibody design
Abstract Synthetic antibodies (Abs) represent a category of artificial proteins capable of closely emulating the functions of natural Abs. Their in vitro production eliminates the need for an immunological response, streamlining the process of Ab discovery, engineering, and development. These artifi...
Main Author: | Eugenio Gallo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12929-024-01018-5 |
Similar Items
-
Generation and Next-Generation Sequencing-Based Characterization of a Large Human Combinatorial Antibody Library
by: Hye Lim Choi, et al.
Published: (2023-03-01) -
Longitudinal analysis of the antibody repertoire of a Zika virus-infected patient revealed dynamic changes in antibody response
by: Xuefeng Niu, et al.
Published: (2020-01-01) -
Looking for therapeutic antibodies in next-generation sequencing repositories
by: Konrad Krawczyk, et al.
Published: (2019-10-01) -
Engineered mRNA and the Rise of Next-Generation Antibodies
by: Laura Sanz, et al.
Published: (2021-09-01) -
A Customizable Suite of Methods to Sequence and Annotate Cattle Antibodies
by: Kristel Ramirez Valdez, et al.
Published: (2023-06-01)